Home Tools
Log in
Cart

Search Result

Search Results for " african trypanosomiasis "

17

Compounds

Cat No. Product Name Synonyms Targets
T27135 DDD85646 DDD 85646,DDD-85646 Parasite
DDD85646 is an inhibitor of T. brucei N-myristoyltransferase with a Ki of 1.44 nM, an IC50 of 2 nM and an EC50 of 2 nM. The IC50 of hNMT is 4 nM.
T77645 JC-229 TRP/TRPV Channel
JC-229 is a potent and selective TbRPA1 inhibitor that can inhibit RPA1 in Trypanosoma brucei. JC-229 can be used to study human African Trypanosomiasis (HAT).
T67919 NMT-IN-1 Others
NMT-IN-1 is a potent inhibitor of N-nutyltransferase (NMT), with IC50 of 31μM for TbNMT and 66μM for hNMT. NMT-IN-1 is a potential compound for the treatment of African trypanosomiasis.
T33278 Melarsoprol Melarsoprolum,RP 3854,RP3854,RP-3854
Melarsoprol, an organoarsenic compound, can be used to treat trypanosomiasis (human African sleeping sickness).
T34663 S-MGB-234 TFA SMGB-234,SMGB 234,S-MGB-234,S-MGB234,SMGB234,S-MGB 234
S-MGB-234 is a novel Minor Groove Binder that cures animal African trypanosomiasis in an in vivo mouse model. S-MGB-234 has significant potential as novel therapeutic agents for animal African trypanosomiasis.
T24587 Pafuramidine maleate DB-289,DB289,DB 289
Pafuramidine is an orally bioavailable prodrug of formamidine which was developed for the treatment of human African trypanosomiasis.
TN5588 Kolavenol
Kolavenol shows a trypanocidal activity with an IC50 value of 2.5 microg/ml (8.6 microM) against Trypanosoma brucei rhodesiense, the causing agent of the acute form of human African trypanosomiasis.
T40789 Eflornithine hydrochloride MDL71782hydrochloride,RMI71782hydrochloride,DFMO hydrochloride,α-difluoromethylornithinehydrochloride
Eflornithine hydrochloride, a specific and irreversible inhibitor of ornithine decarboxylase enzyme, is a medication used for the treatment of African trypanosomiasis and excessive facial hair growth in women.
T40811 Eflornithine RMI71782,α-difluoromethylornithine,DFMO,MDL71782
Eflornithine is an irreversible inhibitor that specifically targets the enzyme ornithine decarboxylase. It serves as a therapeutic medication for two conditions: the treatment of African trypanosomiasis and the managemen...
T72267 Antitrypanosomal agent 9
Antitrypanosomal agent 9 is a potent compound with inhibitory activity against T. b. brucei, exhibiting an IC50 of 1.15 μM. It is utilized in research for human African trypanosomiasis (HAT).
T79254 Antitrypanosomal agent 14 Parasite
Antitrypanosomal agent 14 (Compound 1), a potent T. brucei inhibitor with an effective concentration (EC50) of 0.47 μM, also inhibits Tb GSK3 with an inhibitory concentration (IC50) of 12 μM, and is utilized in the resea...
T79253 HAT-IN-8 Parasite
HAT-IN-8 (Compound 38), a blood-brain barrier-permeable inhibitor of Trypanosoma brucei with an EC50 of 0.18 μM, is utilized in the study of Human African trypanosomiasis [1].
T39397 S-MGB-234
S-MGB-234 is a minor groove binder utilized for the treatment of Animal African Trypanosomiasis (AAT). It exhibits exceptional in vitro efficacy against the primary causative agents of AAT, namely Trypanosoma congolense ...
T62362 GNF6702
GNF6702 is a selective inhibitor of the kinetoplastid proteasome and has been shown to be effective against parasites in mouse models of leishmaniasis, Chagas disease and human African trypanosomiasis.
T14115 Acoziborole SCYX-7158,AN5568 Others
Acoziborole (SCYX-7158), a derivative of benzoxaborole, is a safe, effective and structurally novel antigen-worm agent for human African trypanosomiasis (HAT) studies. The MIC value of Acoziborole for T. b. brucei S427 w...
T62255 20S Proteasome-IN-4
20S Proteasome-IN-4 (Compound 7) is an orally active inhibitor of the 20S proteasome, selectively targeting the parasite form and demonstrating brain penetration capabilities. It exhibits a potent IC50 value of 6.3 nM ag...
T79568 NPD-2975 Parasite
NPD-2975 (compound 30) is an orally active antitrypanosomal agent effective against Human African Trypanosomiasis (HAT), demonstrating acceptable metabolic stability and low toxicity potential in human MRC-5 lung fibrobl...
TargetMol